Literature DB >> 21325550

Clinical significance of Propionibacterium acnes recovered from blood cultures: analysis of 524 episodes.

Hyun Jung Park1, Shin Na, Seong Yeon Park, Song Mi Moon, Oh-Hyun Cho, Ki-Ho Park, Yong Pil Chong, Sung-Han Kim, Sang-Oh Lee, Yang Soo Kim, Jun Hee Woo, Mi-Na Kim, Sang-Ho Choi.   

Abstract

Of 522 patients with Propionibacterium acnes bacteremia (PAB), 18 (3.5%) had clinically significant PAB. Of these 18 patients, 10 (55.6%) had hospital-acquired bacteremia and 6 (33.3%) had undergone invasive procedures before development of PAB. One patient with a ventricular septal defect presented with infective endocarditis. After the exclusion of 1 patient whose outcome was not available, the overall mortality rate was 5.9% (1/17).

Entities:  

Mesh：

Year:  2011        PMID： 21325550      PMCID： PMC3122867          DOI： 10.1128/JCM.01842-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Propionibacterium acnes endophthalmitis.

Authors:  G Vafidis
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

2.  Infectious arthritis due to Propionibacterium acnes in a prosthetic joint.

Authors:  M S Sulkowski; I Z Abolnik; E I Morris; D L Granger
Journal:  Clin Infect Dis       Date:  1994-07       Impact factor: 9.079

3.  Endocarditis due to Propionibacterium acnes.

Authors:  J F Lewis; J H Abramson
Journal:  Am J Clin Pathol       Date:  1980-11       Impact factor: 2.493

4.  Propionibacterium acnes osteomyelitis: case report and review of the literature.

Authors:  R C Noble; S B Overman
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

Review 5.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

6.  Focal infections of the central nervous system due to Propionibacterium acnes.

Authors:  J Richards; H R Ingham; J Hickman; P J Crawford; R P Sengupta; A D Mendelow
Journal:  J Infect       Date:  1989-05       Impact factor: 6.072

7.  Risk factors for mortality in patients with anaerobic bacteremia.

Authors:  J R Wilson; A P Limaye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

8.  Septic arthritis caused by Propionibacterium acnes.

Authors:  R C Yocum; J McArthur; B G Petty; A M Diehl; T R Moench
Journal:  JAMA       Date:  1982-10-08       Impact factor: 56.272

9.  Anaerobic bacteraemia in patients admitted to Auckland City Hospital: its clinical significance.

Authors:  Sharmini Muttaiyah; Sue Paviour; Leanne Buckwell; Sally A Roberts
Journal:  N Z Med J       Date:  2007-11-09

10.  Infections caused by Propionibacterium species.

Authors:  I Brook; E H Frazier
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct
View more
  17 in total

Review 1.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Multiple splenic nodules with fever: a case of splenic abscess due to Propionibacterium acnes.

Authors:  Sho Kiritani; Junichi Kaneko; Taku Aoki; Yoshihiro Sakamoto; Kiyoshi Hasegawa; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Clin J Gastroenterol       Date:  2013-10-10

3.  Utility of strain typing of Propionibacterium acnes in central nervous system and prosthetic joint infections to differentiate contamination from infection: a retrospective cohort.

Authors:  J P Burnham; A Shupe; C-A D Burnham; D K Warren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-25       Impact factor: 3.267

4.  Prospective Study of the Detection of Bacterial Pathogens in Pediatric Clinical Specimens Using the Melting Temperature Mapping Method.

Authors:  Yoji Uejima; Eisuke Suganuma; Takuma Ohnishi; Haruka Takei; Mihoko Furuichi; Satoshi Sato; Yutaka Kawano; Isao Kitajima; Hideki Niimi
Journal:  Microbiol Spectr       Date:  2022-06-08

Review 5.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species.

Authors:  Abdelghani El Rafei; Daniel C Desimone; M Rizwan Sohail; Christopher V Desimone; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Pacing Clin Electrophysiol       Date:  2016-04-22       Impact factor: 1.976

7.  De Novo meningitis caused by Propionibacterium acnes in a patient with metastatic melanoma.

Authors:  Jason P Burnham; Benjamin S Thomas; Sergio E Trevino; Erin McElvania Tekippe; Carey-Ann D Burnham; F Matthew Kuhlmann
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

8.  Altered profile of human gut microbiome is associated with cirrhosis and its complications.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Phillip B Hylemon; Arun J Sanyal; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel B Unser; Kalyani Daita; Andmorgan R Fisher; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  J Hepatol       Date:  2013-12-25       Impact factor: 25.083

9.  A 454 survey reveals the community composition and core microbiome of the common bed bug (Cimex lectularius) across an Urban Landscape.

Authors:  Matthew Meriweather; Sara Matthews; Rita Rio; Regina S Baucom
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Importance of Coryneform Bacteria in Infective Endocarditis.

Authors:  Alexander von Graevenitz
Journal:  Infect Dis Rep       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.